Latest Event Updates
3D Technology Market is Expected to Reach $175.1 Billion, Globally, by 2020 – Allied Market Research
Allied Market Research today announced the most comprehensive and strategically analyzed report titled “Three-Dimensional (3D) Technology Market by Products (3D Printing, 3D Glasses, 3D Cameras, 3D Displays), Applications (3D Printing Industry, Entertainment, Healthcare, Government and Defense, Aerospace, Industrial and Manufacturing, and Architecture) and Software (3D scanning, 3D Modeling, 3D Rendering, 3D animation, 3D reconstruction) Size, Share, Trends, Analysis, Growth and Global Forecast, 2012 – 2020“.
Get full access of the report at http://www.alliedmarketresearch.com/3d-technology-market
The study observed that the global 3D technology market was valued at $46.0 billion in 2013, and is estimated to reach $175.1 billion, by the end of 2020, growing at a CAGR of 21% during 2013-2020. North America is the largest geographical segment for the 3D technology market in 2013, accounting for about 40.9% revenue. Entertainment remains the largest application segment, while 3D printing application is expected to exhibit the fastest growth during the forecast period.
The three-dimensional (3D) technology has gradually evolved as primary technique for modeling, prototyping and imaging in various applications over the past few years. With higher level of accuracy, lower privacy risk, precision in data, easier reverse engineering, and better communication platform, the 3D technology market is expected to grow at CAGR of 21% during 2013-2020. However, higher cost, lower awareness and lack of infrastructure are hindering the market growth.
The ever increasing adoption of 3D technologies in various application segments such as healthcare, aerospace, entertainment, and architecture is compounding the growth of the 3D technology market. Among various applications, entertainment industry generated the maximum revenue in 2013, followed by the healthcare segment. Entertainment industry accounted for about 39% of the global market in 2013, and the market is expected to grow at CAGR of 22.3% during 2013 – 2020. Major factors responsible for this growth are high quality of service provided by 3D devices in terms of resolution, accuracy, depth perception, enhanced display capabilities and lowered risk of piracy. In addition, 3D printing industry is projected to be the most attractive segment in the overall application market, accounting for about 5.3% of 3D technology market revenue in 2020. Aerospace would be the segment of focus for 3D printing industry during forecast period, whereas, healthcare would also render growth prospects for 3D printing.
In 3D product market, 3D displays generated maximum revenue in 2013, followed by 3D imaging software; however, 3D printing will be the fastest growing product segment during the forecast period. In the geography market, North America will continue to lead in revenue generation, mainly due to access to better infrastructure and adoption of advanced technology among the end users. The fastest growing market is projected to be Asia Pacific region during the analysis period.
IP Video Surveillance and VSaaS Market Expected to Reach $57.3 Billion by 2020 – Allied Market Research
The new market research report titled “IP Video Surveillance and VSaaS Market (Technologies, Applications, Services, Geography) – Industry Analysis, Trends, Share, Opportunities and Forecast, 2012 – 2020″, published today by Allied Market Research. As per the market study, the global IP Video Surveillance and VSaaS market is expected to reach $57.3 Billion by 2020. North America is expected to experience highest share in IP Surveillance market by 2020. Asia Pacific is expected to grow with highest CAGR 44.3% during analysis period 2013-2020. North America would be the highest revenue generating segment with a value of $18,741.6 million in 2020.
Get full access to the report at http://www.alliedmarketresearch.com/IP-video-surveillance-VSaaS-market
IP Surveillance market is undergoing an evolutionary phase in developing countries therefore promising significant potential. In case of developed countries, the analogue surveillance systems are being actively replaced by IP surveillance systems. Increasing awareness regarding the benefits of IP based surveillance system, favorable regulatory impositions and rising security concern are the key factors expected to catalyze the growth of IP Surveillance market during the forecast period. Penetration of internet protocol in surveillance has created a long lasting impact on the overall surveillance industry.
“IP Surveillance system is widely accepted in developed markets and the adoption rate is expected to increase in developing markets such as Asia-Pacific,” states AMR analyst Bryan Olson. Government and higher security segment is expected to adopt IP surveillance system at a faster pace during the analysis period, growing at a CAGR of 39.2% from 2013 to 2020. Banking and financial institutes are expected to be the highest revenue generating segment within the application market. IP surveillance hardware market is expected to be the highest revenue-generating segment with estimated revenues of $24.3 billion by 2020.
IP Surveillance system serves better flexibility and scalability features in comparison to the CCTV and conventional surveillance systems. Analog systems are expandable only to a specific limit: for instance, only limited number of cameras can be added to the existing infrastructure. However, IP surveillance system is creating better opportunity for end-users willing to focus on multi-level or multi-site business expansions. For this reason, organizations are expected to prefer IP surveillance systems over analog systems.
IP surveillance system is configured with advanced technology such as video motion detection, frame rate control, automatic brightness control, internal storage memory, and remote-zoom facility. From another perspective, rising security concern and technological advancements throughout the globe is acting as a strong driving force for the market. IP surveillance systems integrated with video analytics enable high level of intelligence, therefore enhancing security. Such systems are evidencing higher adoption rates in security sensitive segments such as airports, casinos and so on.
IP surveillance systems are directly connected to the internet and this makes the system and associated sensitive data, vulnerable to hackers. Technological innovations are expanding the application areas of the surveillance systems anywhere from healthcare setups to public places. This is perceived to cause major concerns with respect to privacy of individuals especially in countries such as North America and Europe where the privacy laws are comparatively stringent.
This report segments the IP surveillance market based on products, applications and geographies. This report encapsulates company profiles of ten leading companies dealing in IP Surveillance systems namely, Avigilon Corporation, Axis Communication AB, D-Link Corporation, Genetec, March Networks, Milestone Systems, Panasonic Corporation, Mobotix AG, GeoVision Inc. and Arecont Vision.
Along with the benefits of IP surveillance systems, the public needs to be educated about the privacy issues related to monitoring. This can be done by educating the public on issues such as general norms and objectives of deploying surveillance systems, existing privacy laws, penalties and method of reporting for any breach of surveillance and privacy laws etc. This will instill confidence among the public.
Biomarker Market for Diagnostic Applications is Expected to Reach $30.6 Billion Globally by 2020 – Allied Market Research
According to a new report titled “Biomarkers Market (Diagnostic Applications in Risk Assessment, Molecular Diagnostics, Disease Diagnosis, Drug Discovery & Development, Drug Formulation, Forensic Applications and Others) – Global Industry Analysis, Emerging Technologies, Competitive Intelligence, Growth Trends, Size, Share, Opportunities and Forecast, 2013 – 2020” published by Allied Market Research, the global biomarkers market for diagnostic applications such as risk assessment, molecular diagnostic, disease diagnosis, drug discovery & development, drug formulation, forensic and other such applications is set to reach about $30.6 billion in 2020 growing at CAGR of 16% from 2013 to 2020. Disease diagnostic remains the key application segment that is expected to reach $6.1 billion in 2020. However application of diagnostic biomarkers in forensics and molecular diagnostics is catching up quite significantly with latter expected to experience a growth rate of 17.6% during 2013 and 2020.
The complete report is available at http://www.alliedmarketresearch.com/biomarkers-market
“Diagnostic biomarkers continue to address challenges such as early and accurate diagnosis of most of the fatal diseases. Increasing advancements with extended applications of diagnostic biomarkers are only going to increase its significance in the field of diagnostics” according to AMR analysts Debbie Shields and Roshan Deshmukh. “Diagnostic biomarker technology is expected to change the scenario of drug development and medical practice, as technologies are metamorphosing from traditional pathophysiology/epidemiology approach to biomarker studies such as genomics and proteomic” add the analysts.
Diagnostic biomarkers though are a great tool in molecular diagnostics, is facing challenges with respect to ethical and regulatory issues as these are related to genomic pattern of an individual which needs to be extremely confidential.
This report segments the global diagnostic biomarker on the basis of diagnostic biomarker types, applications and service. Applications market is further segments as risk assessment, molecular diagnostics, disease diagnosis, drug discovery and development, drug formulation, forensic applications and others. The report particularly focuses on biomarkers for diagnostic applications and excludes clinical trials and research.
With respect to geography, Asia Pacific is expected to have the highest CAGR at 20.3% from 2013 to 2020. Companies profiled in this report include Roche Diagnostic Limited (Switzerland), Siemens Healthcare (Germany), Abbott Laboratories Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Agilent Technologies Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), Aushon BioSystem Inc. (U.S.), Epistem Ltd. (U.K.), G.E. Healthcare Inc. (U.K)
Polylactic Acid Market is Expected to Reach $5.2 Billion Globally by 2020, According to Allied Market Research
Allied Market Research today announced its comprehensive and strategically analyzed market intelligence report titled – “Polylactic Acid (PLA) Market in Packaging, Textile, Agriculture, Transportation, Bio-Medical, Electronics and Others – Global Industry Size, Company Share, Growth, Trends, Strategic Analysis and Forecast, 2012 – 2020”. According to the research report, the global Polylactic Acid (PLA) market is expected to reach $5.2 billion by 2020 growing at a CAGR of 19.5% from 2013 to 2020. Asia Pacific will be the fastest growing market at a CAGR of 21.6% during this period whereas Europe will maintain its lead in terms of revenue till 2020, despite having a comparatively slower growth.
Get full access of the report at http://www.alliedmarketresearch.com/polylactic-acid-market
“Governments across the globe havebeen instrumental in imposing ban on the use of fossil fuel-based products such as plastic bags and are also providing incentives for bio-based PLA production. Moreover, the rising petrochemical prices in association with growing awareness for environment safety have been the prime contributors towards the growth of Polylactic Acid market” state AMR analystsSarah Clark and Ranjan Singh. “The ongoing research onreinforcement of PLA with other materials would bring opportunities for PLA with much improved products in future.” add the analysts.
Low-cost and easy availability of raw materials are key factors that are contributing to the cost-effectiveness of PLA. The production costs are however, expected to further reduce with research focused on identifying alternative sources of raw materials. On the contrary, certain restraining factors too exist which will restrain the growth of PLA market. “Need for industrial composting to completely degrade PLA, will act as an important restraint” said Clark and Singh.
The report analyzes the global polylacticacid market under categories namely application and raw materials. The applications category, it is further segmented as per the sector in which PLA is utilized to manufacture the final product. These are Packaging, Textile (Woven and non-woven), Electronics, Biomedical, Agriculture, and other such applications. Packaging has been the largest application segment for PLA and will continue to hold lead position during the forecast period; however, textiles and electronics will be adopting PLA more rapidly. The raw materials analyzed in this report include, Corn, Tapioca, Sugarcane and Wheat. Tapioca and sugarcane are the primary raw materials used by PLA manufacturers all around the world.
On the basis of geographical regions, the market has been segmented under regions namely North America, Europe, Asia Pacific and rest of the world. Plentiful feedstock from agriculture and strong government incentive programs will increase opportunity for rise in production of PLAin Asia Pacific, which will largely contribute to its faster market growth.
The study includes an in-depth analysis of the leading market players in the market and provides detailed company profiles of the following leading manufacturers of PLA – Nova Chemicals Corporation, Dow Chemical, Eastman Chemical, Nature Works, DuPont Corporation, Bayer AG, Exxon Mobil Chemical, Mitsubishi Chemical Corporation (MCC), China Petroleum & Chemical Corporation (Sinopec), Braskem.
Global Umbilical Cord Blood Stem Cell Market is Expected to Reach $56.4 Billion by 2020 – Allied Market Research
Allied Market Research today announced the most comprehensive and strategically analyzed report titled “Stem Cell Umbilical Cord Blood (UCB) Market (Storage Services, Therapeutics, Applications and Geography) – Size, Share, Global Trends, Analysis, Opportunities, Growth, Intelligence and Forecast, 2012 – 2020″ The study observed that the global umbilical cord blood stem cell market is forecasted to reach market value over $11.5 billion in 2014 from $ 6.5billion in 2012.Developments and approvals for novel cord blood stem cells therapies is expected to drive the market growth. The market is expected to reach revenue of $56.4 billion by 2020, growing at CAGR of 33.4%during 2013 to 2020.The storage service market was valued at $7.4billion in 2013.
Get Full access of the report at http://www.alliedmarketresearch.com/stem-cell-umbilical-cord-blood-UCB-market
“Cord blood stem cell application is increasing at faster rate than other stem cell techniques because of its efficient and cost effective treatment process. Cord blood is assisting thehealthcare industry to discover novel therapies on chronic diseases. UCB stem cell market is evidencing significant growth due to increasing public awareness and government support.”state Allied Market Research analyst Debbie Shields and Roshan Deshmukh.
Increase in prevalence rate of chronic diseases such as cancer, diabetes, blood disease, immune disease, metabolic disease etc. has increased the need of cost effective and efficient way of treatment. However, cord blood stem cells have the potential to treat these chronic diseases effectively. These stem cells have special property of higher cell count in lower blood volume. Collection of these stem cells is much easier than other stem cells and could be stored in specialized preservation facilities called as Cord Blood Stem Cell Banks.
Cord blood stem cells market is in its emerging phase. Significant applications of stem cells in the treatment of various disorders will be commercialized very soon as most of them are in the last phase of clinical trials. Patents for collection techniques and therapeutics methods are approved by respective government of developed countries however patents for UCB stem cells are comparatively less in developing economies.
According to lead analyst Debbie Shields, the geographicanalysis shows that the North American market for cord blood stem cell would account for approx. 44% of total revenue generated by the cord blood market in 2013. However, much expected growth is to occur in Asia-Pacific regions during the forecast period, because of growing demand for chronic disease treatments and widely increasing awareness levels. This report study offers updated review about major market players present in this market such as researcher based pharmaceutical companies and therapeutics services companies.Company profiles in this report include – Advanced Cell Technology Inc., California Stem Cell Inc., Cytori Therapeutics Inc., Mesoblast Limited, Opexa Therapeutics Inc.(USA), Athersys Inc., Geron Corporation, and Neostem Inc.
Continuous Glucose Monitoring (CGM) Market will Reach $568.5 Million Globally by 2020 – Allied Market Research
According to the new market research report titled “Continuous Glucose Monitoring Market (CGM Systems, Application, Diabetic Type, and Adoption by Age Group) – Current Trends, Size, Share, Industry Analysis, Competitive Intelligence, Growth, Opportunities and Global Forecasts, 2012 – 2020” by Allied Market Research, the global continuous glucose monitoring (CGM) market is projected to reach $568.5 million by 2020 from 2012 value of $194.8 million growing at a CAGR of 14.8% during 2013 – 2020. The major factors driving the market growth are convenience offered by CGM over conventional glucose monitoring devices, earlier detection of the hypo and hyperglycemic events, rise in incidences of diabetes cases globally, and awareness among global population.
The complete report is available at http://www.alliedmarketresearch.com/continuous-glucose-monitoring-cgm-market
“The market is overcoming several challenges towards the commercialization of closed loop CGMs with significant focus on technological innovation. This is expected to take the concept of CGM to a next level from research to mass adoption” noted AMR analyst Debbie Shields. Despite such encouraging innovations, commercialization has not reached to desired levels. Major factors responsible for this are issues related with accuracy as well as cost, less attractive reimbursement coverage, and strict regulatory impositions. “However, the under commercialization is presenting opportunities for the marketers as new and innovative products will easily take the advantage of lower product presence” Debbie explains. The impact of FDA approval for artificial pancreas, superiority of CGMs over self-monitoring devices and rise in diabetes cases will have significant impact on the overall market growth.
The market is categorized into CGM devices, application, type of diabetes, and on the basis of age. In the CGM application market, home settings was largest revenue generating segment in 2012. CGM application in hospitals is expected to emerge to be the most attractive segment in the overall application market during the forecast period.
In the overall market, largest revenue is projected to be generated from glucose sensors. This is mainly due to the fact that more improvement is expected in the sensors during forecast period.
Transmitters and receivers market accounted for the largest share of revenue of the overall Global continuous glucose monitoring systems market at $88.5 million in 2012. However, Glucose sensors market will surpass transmitters & receivers and attain a market size of $235.9 million by 2020 growing at a CAGR of 15.3% during 2013-2020. Insulin pumps segment is expected to have the highest growth rate during the analysis period.
North America region accounted for the largest share of revenue of the overall global continuous glucose monitoring systems market in 2012, whereas Asia Pacific will have the highest growth rate during the analysis period.
The report analyzes 2011, 2012 market and forecast demand for continuous glucose monitors through 2020. Companies profiled in this report include Medtronic Inc., Dexcom Inc., Novo Nordisk, Spring Health Solution Ltd, Roche, Animas Corporation, Ypsomed AG, and Insulet Corporation.
Allied Market Research today announced the most critically analyzed report titled “Global Smart Homes, Buildings (Energy Efficient, Automated) Market (Applications, Technologies, Products and End-User), Size, Share, Trends, Analysis, Research, Future Demand, Scope and Forecast, 2013 – 2020″. The study concludes that the global smart home and buildings market is expected to grow at a CAGR of 29.5% between 2012 and 2020. The market revenue of $4.8 billion in 2012 is expected to grow up to $35.3 billion by 2020. The main drivers for the growth of the market are government regulations, rising energy costs and raising awareness with respect to environmental concerns.
Get Full Access of the Report at http://www.alliedmarketresearch.com/smart-home-automated-building-market
Energy efficiency has become the need of the hour as the global energy cost is increasing owing to the ever growing demand and environmental concerns of greenhouse gas (GHG) emission. The construction business is embracing the energy efficiency trend and using building automation system to meet the growing demand for energy efficiency in smart homes and buildings. The global smart, automated and energy efficient homes and buildings market report published by Allied Market Research discusses the in-depth analysis of this market which includes the drivers, restraints and opportunities for its growth.
The revenue of safety and security application is expected to reach $6,132.4 million by 2020 with an expected CAGR of 34.6% from 2013 to 2020. “This market is expected to evidence significant growth due to growing security concerns and enhanced safety features that smart automation systems can currently offer. With an increase in the working population, safety concernswith respect to aged parents and children is the biggest challenge. Smart home address these issues with highly-sophisticated remote monitoring technologies.” states Shreyas Naidu.
However, there are some factors such as high upfront cost and lack of standards and interoperability which are expected to act as restraints for the market growth. North America is expected to generate revenue of $12.4 billion by 2020 growing at a CAGR of 25.9% from 2013 to 2020. However the Asia-Pacific is a high-opportunity market that is expected to grow at a CAGR of 37.7% from 2013 to 2020.
The report has profiled some of the key players of the market such as Cisco Systems, Control4 Corporation, Emerson Electric Co. Leviton, Honeywell International, LG Electronics, Schneider Electric, Siemens Buildings Technologies, Smarthome Inc., and United Technologies Corporation (UTC).The report also discusses the key strategies used by these companies to have a sustainable growth in the market.